Subsequent events	12 Months Ended
Dec. 31, 2019
Subsequent Events [Abstract]
Subsequent events	Note 10 – Subsequent Events On April 3, 2020, GeneThera entered into a preliminary agreement with Green RV Storage LLC for the purchase of a 16,000 square foot building located in the planned Northwest 36 Biotechnology Center in Broomfield, Colorado. The new state of the art facility will be the Company administrative and R&D facility. The development is scheduled to be completed in fall of 2021. The impact of COVID-19 on the Company is unknown at this time. The financial consequences of this situation cause uncertainty as to the future and its effects on the economy and the Company. Presently the Company is considering ways to apply its molecular robotic technology to address the COVID-19 pandemic As of June 10, 2020, no additional conversions have occurred, and no new convertible notes have been issued. During the second quarter, the Company has cancelled 7,064,967 shares of common stock that have been held in escrow originally issued to independent contractors for capital raise efforts. The stock certificates were returned to the Company and has not or will not be given to the independent contractors.

Subsequent events

12 Months Ended

Dec. 31, 2019

Note 10 – Subsequent Events

On April 3, 2020, GeneThera entered into a preliminary agreement with Green RV Storage LLC for the purchase of a 16,000 square foot building located in the planned Northwest 36 Biotechnology Center in Broomfield, Colorado. The new state of the art facility will be the Company administrative and R&D facility. The development is scheduled to be completed in fall of 2021.

The impact of COVID-19 on the Company is unknown at this time. The financial consequences of this situation cause uncertainty as to the future and its effects on the economy and the Company.

Presently the Company is considering ways to apply its molecular robotic technology to address the COVID-19 pandemic

As of June 10, 2020, no additional conversions have occurred, and no new convertible notes have been issued.

During the second quarter, the Company has cancelled 7,064,967 shares of common stock that have been held in escrow originally issued to independent contractors for capital raise efforts. The stock certificates were returned to the Company and has not or will not be given to the independent contractors.